Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.290
+0.070 (1.66%)
At close: Mar 9, 2026, 4:00 PM EDT
4.250
-0.040 (-0.93%)
After-hours: Mar 9, 2026, 4:24 PM EDT
Aquestive Therapeutics Employees
Aquestive Therapeutics had 147 employees as of December 31, 2025. The number of employees increased by 5 or 3.52% compared to the previous year.
Employees
147
Change (1Y)
5
Growth (1Y)
3.52%
Revenue / Employee
$303,027
Profits / Employee
-$569,959
Market Cap
523.57M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 420 |
| Evolus | 334 |
| Esperion Therapeutics | 304 |
| Ironwood Pharmaceuticals | 253 |
AQST News
- 40 minutes ago - Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 days ago - AQUESTIVE THERAPEUTICS, INC. (AQST) INVESTOR ALERT Investors With Large Losses in Aquestive Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 3 days ago - AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Aquestive Therapeutics - Business Wire
- 4 days ago - Aquestive Therapeutics, Inc. (AQST) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - PRNewsWire
- 4 days ago - Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 days ago - AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - GlobeNewsWire
- 9 days ago - AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - PRNewsWire